Pre header text goes here. Will show on inbox
To view this email as a web page, click here.

 
ADVERTISEMENT
Ad description here
 
COMMUNITY REPORT
 
Health Care a Big Issue in President Trump's Speech to Congress
In his speech to Congress, President Donald J. Trump again called for the repeal and replacement of the Affordable Care Act, also known as Obamacare, and called for "reforms that expand choice, increase access, lower costs, and at the same time provide better health care."
Read more
 
ADVERTISEMENT
 
POPULAR ON THE WEB
 
How Did You Participate in Rare Disease Day 2017?
This important event is helping to raise awareness in over 90 countries. What did you do to get involved?
 
How to Deal with an Angry Customer
With rises in co-pays and issues with denied prescriptions more pharmacists are seeing angry customers. What can you do?
 
Food, Juice, and Drugs: Hold the Grapefruit
Many drugs are known to have interactions with foods and beverages. But are patients educated well enough about these interactions?
 
EDITOR'S CHOICE
 
Pfizer receives FDA warning
In a letter from the FDA made public on February 28, a Pfizer plant in McPherson, KS, was accused of ignoring several complaints and safety procedures.
Read more
 
INSIDE THE LATEST ISSUE
 
Five Innovative New Products for Diabetes
image description here We take a look at some of the latest breakthroughs in the treatment of diabetes.

 
CONTINUING EDUCATION
 
Human papillomavirus (HPV) vaccine: Updated recommendations and strategies to improve
New Options When Statins Are Not Enough
Key cogs in the management of Parkinson's disease
 
DIGITAL EDITION
 
February 2017 | Vol. 161 No. 2
In this issue, find out what a Trump administration could mean for you, and take another look at specialty pharmacy before it's too late. We also take a look at the importance of standardization and discuss food interactions.

Read the whole issue here
 
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.